X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BLOOD CELLS MOLECULES AND DISEASES

期刊標題檢索 BLOOD CELL MOL 最新評論: Is it okay to submit submissions now? How long is the submission perio... (2024-02-15)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BLOOD CELLS MOLECULES AND DISEASES]您好,您是該頁面的第 17415 位訪客。

期刊簡介
期刊名稱BLOOD CELLS MOLECULES AND DISEASES BLOOD CELLS MOLECULES AND DISEASES
LetPub Score
5.5
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
9.7

期刊簡稱BLOOD CELL MOL DIS
ISSN1079-9796
E-ISSN1096-0961
h-index82
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.900.5840.547
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q249 / 137
Category: Medicine
Subcategory: Molecular Medicine
Q3111 / 178
Category: Medicine
Subcategory: Molecular Biology
Q3258 / 410
Category: Medicine
Subcategory: Cell Biology
Q3193 / 285

自引率 (2023-2024)4.80%自引率趨勢
掲載範囲
Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.
官方網站http://www.journals.elsevier.com/blood-cells-molecules-and-diseases/
在線稿件提交http://ees.elsevier.com/bcmd/default.asp?pg=login.asp
開放訪問No
出版商Academic Press Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1995
每年文章數31每年文章數趨勢
黃金OA百分比12.70%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ358/97
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1079-9796%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
在線文章發布時間來自Elsevier的數據: Average 5.8 Week(s)
參考鏈接
相關期刊 【BLOOD CELLS MOLECULES AND DISEASES】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Hematology & OncologyH-index: 60

    CiteScore: 48.10
    BLOODH-index: 426

    CiteScore: 23.60
    LEUKEMIAH-index: 176

    CiteScore: 18.10
    AMERICAN JOURNAL OF HEMATOLOGYH-index: 92

    CiteScore: 15.70
    HAEMATOLOGICAH-index: 125

    CiteScore: 14.10
    BLOOD REVIEWSH-index: 85

    CiteScore: 13.80
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYH-index: 111

    CiteScore: 11.00
    BRITISH JOURNAL OF HAEMATOLOGYH-index: 172

    CiteScore: 8.60
    SEMINARS IN HEMATOLOGYH-index: 88

    CiteScore: 6.20
    HEMATOLOGICAL ONCOLOGYH-index: 42

    CiteScore: 4.20
    學科內最受檢索的期刊 頁面查看次數
    BLOOD111059
    Journal of Hematology & Oncology101270
    LEUKEMIA58208
    BRITISH JOURNAL OF HAEMATOLOGY50947
    LEUKEMIA & LYMPHOMA44527
    Hematology37488
    ANNALS OF HEMATOLOGY36129
    AMERICAN JOURNAL OF HEMATOLOGY35419
    LEUKEMIA RESEARCH34145
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY32883
  •  

    BLOOD CELLS MOLECULES AND DISEASES BLOOD CELLS MOLECULES AND DISEASES
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [BLOOD CELLS MOLECULES AND DISEASES] 的評論撰寫評論
作者: 兰花涵亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-15 21:41:00 評論於
Is it okay to submit submissions now? How long is the submission period?
(0) 讚! | 兰花涵亦

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:50:57 評論於
The method of relative quantification in qPCR is the ΔΔCT method, first calibrating with a reference gene, and then calculating the difference between the sample and control groups
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:19:05 評論於
Please translate the following paragraph into English and Japanese, with titles ":" and ":"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:30:33 評論於
How to handle the results of qPCR?
(0) 讚! | 龙鳞孝礼

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 16:18:02 評論於
Can my search results include video results?
(0) 讚! | Darlene Pepys

作者: 蚀骨香芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-25 08:37:46 評論於
What direction are you in?
(0) 讚! | 蚀骨香芹

作者: Eilis


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2018-11-23 17:47:09 評論於
Although this journal was quite good years ago, it has become worse and worse in recent years. Reconsider submitting.

(0) 讚! | Eilis

作者: 凌霄秀梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-23 16:06:17 評論於
Review Speed: 1.0 | Submission Hit Rate: 75.0
Sharing Experience: It was pretty good before, but it's been getting worse in recent years. Could it drop to Zone 4?
(0) 讚! | 凌霄秀梅

作者: 璃沙依冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-06 10:45:07 評論於
Are you still accepting case reports?
(0) 讚! | 璃沙依冬

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 14:43:39 評論於
Damn it, last year I scored over 2 points for an article I published, but this year it's just over 1 point. Will it drop even further next year? Who would want to invest in it?!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 13:55:01 評論於
Too harsh! After such a big drop, who dare to invest in the future??
(0) 讚! | 凌霄高洁

作者: Cara Howells


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-10-31 15:24:54 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Experience sharing: I have submitted to this journal twice this year. The first time, my case report was instantly rejected because the journal no longer accepts case reports. The second time, I submitted on October 8, 2016, and the status was "with editor" until October 30, when it suddenly changed to "accept." I couldn't believe it, it was accepted without being sent out for review. I thought the editor was on vacation, but they accepted it directly. The speed was really fast
(0) 讚! | Cara Howells

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-08-22 10:26:35 評論於
Review Speed: 1.0 Experience Sharing: Before submitting my article, I read several similar articles in this journal and felt that my article was at least better than those. I submitted it in less than a month, but it was sent to a different reviewer midway and ultimately rejected. That's fine, I can accept that my level wasn't good enough. However, the rejection comments were just terrible. It was clear that the reviewer didn't understand the article at all and misinterpreted the issues mentioned. Most of the comments were about not understanding certain sentences or finding contradictions, but did the reviewer actually read the article carefully? They started by saying my article was poorly written and several parts didn't make sense. There wasn't a single valuable suggestion. My article wasn't submitted as is, both my boss and I had already made revisions to it, so there shouldn't have been any language issues as bad as "poorly written," right? And the editor was also irresponsible for accepting such terrible review comments without giving a chance for corrections. I assume the reviewer just passed my article on to a student or someone, who also didn't bother to make changes and just rejected it with a few random comments. It's really disappointing! I hope this is just an isolated case
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-29 23:46:21 評論於
I have submitted an article before, but it was rejected
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [BLOOD CELLS MOLECULES AND DISEASES] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*